Table 2 Associations between clinical factors and serum RASSF1A methylation status
From: RASSF1A hypermethylation in pretreatment serum DNA of neuroblastoma patients: a prognostic marker
Characteristic | Methylated no. | Unmethylated no. | Total no. | P -value |
|---|---|---|---|---|
Age at diagnosis | 0.002 | |||
<12 months | 5 | 37 | 42 | |
⩾12 months | 12 | 14 | 26 | |
Stage | <0.001 | |||
1/2/4S | 3 | 36 | 39 | |
3 | 3 | 8 | 11 | |
4 | 11 | 7 | 18 | |
MYCN | <0.001 | |||
Non-amplified | 5 | 51 | 56 | |
Amplified | 12 | 0 | 12 | |
